Slant Exceeds $6B in Connected AUM in Two Months
New custodian data connections help advisors unify data, automate admin work, and act faster.
"Having our Schwab custodian data flowing into Slant has been a game-changer for us," said
"Two months in, we're seeing a clear signal: advisors want Slant to be the living source of truth," said
Slant's mission is to help 20 million Americans retire with a great financial advisor.
Turning custodian data into action
Custodian data connections are designed to help advisory firms keep client data accurate and up to date, without relying on manual entry or disconnected systems. With Slant, advisory teams can:
- Unify records by linking household and financial data directly to the CRM.
- Get proactive nudges with notifications for large account swings, key milestones, and timely outreach opportunities.
- Improve visibility across accounts to support better follow-up, service, and planning.
- Operate with confidence using a more accurate, consistent client data foundation.
Slant's custodian data connections are available now. To learn more, visit slant.app.
About Slant
Slant is an AI-native CRM and operations hub for financial advisors, powered by Pageport. Slant helps advisory teams turn client data into action—handling meeting prep, follow-up, proactive nudges, scheduling, and other operational tasks while preserving the personal touch. Learn more at slant.app.
Media Contact
Head of Marketing
(385) 342-3244
View original content to download multimedia:https://www.prnewswire.com/news-releases/slant-exceeds-6b-in-connected-aum-in-two-months-302683852.html
SOURCE Pageport
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orbis International and AirAsia Announce Multi-Year Strategic Partnership to Expand Access to Eye Care Across Asia-Pacific
- Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology
- Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share